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Summary.-Adenosine deaminase and adenosine kinase have been measured in rat
liver, 12 transplantable hepatomas, regenerating, foetal and neonatal liver, adult
and neonatal rat kidney and 2 transplantable kidney tumours. Adenosine deaminase
activity, relative to the normal liver value, was elevated 2-4-fold in hepatomas of
rapid growth rate, was in the normal range in more slowly growing hepatomas and
in regenerating liver, and was low in foetal and neonatal liver. Adenosine kinase
activity was decreased, relative to rat liver values, in all the hepatomas; activity of
this enzyme gave a negative correlation with tumour growth rate. Kinetic properties
of the two enzymes were examined in partially purified preparations. Adenosine
deaminases from both liver and rapidly growing hepatoma 3924A were subject to
weak product inhibition by inosine. Adenosine kinase from liver and hepatoma
3924A was inhibited by the reaction products ADP and AMP, and the enzyme was also
subject to excess substrate inhibition by concentrations of ATP in excess of 1 mM. In
rat hepatoma cell lines growing in culture, the toxicity of adenosine correlated
inversely with the ratio of adenosine deaminase activity to adenosine kinase activity.
Chromatographic measurements showed that hepatoma cells incorporated less
extracellular adenosine into their adenine nucleotide pools than did isolated liver
cells. These results indicate that increased adenosine deaminase activity and
decreased adenosine kinase activity may confer a selective advantage upon the
cancer cell.
THE marked abnormalities in the purine
metabolism of hepatomas and other
tumours have been reviewed by Weber
(1977). In other systems there is experi-
mental evidence suggesting that activity of
adenosine deaminase (EC 3.5.4.4, ADA),
which converts adenosine to inosine, may
correlate in some way with cell prolifera-
tion. Congenital deficiency of ADA is
associated with the severe combined
immunodeficiency syndrome (Giblett et al.,
1972; Dissing and Knudsen, 1972; Park-
man et al., 1975). In peripheral lymphoid
cells from patients with chronic lympho-
cytic leukaemia, ADA levels were in the
normal range (Scholar and Calabresi,
1973), but blast cells from patients with
acute lymphoblastic leukaemia and acute
myeloid leukaemia contained markedly
higher ADA activity than normal peri-
pheral leucocytes (Smyth and Harrap,
1975; Meier, Coleman and Hutton, 1976).
Reid and Lewin (1957) found that ADA
activity in a primary azo-dye-induced
hepatoma was in the same range as in
normal liver, and DeLamirande, Allard
and Cantero (1958) showed that ADA
specific activity in Novikoff hepatoma was
twice that of normal rat liver. These pre-
liminary indications of a possible link
between ADA activity and cell prolifera-
tion are ofparticular interest in view ofthe
results of Ishii and Green (1973), who
observed that adenosine was toxic to
cultured mammalian cells by virtue of an
interference with pyrimidine biosynthesis.R. C. JACKSON, H. P. MORRIS AND G. WEBER
The action ofADA is opposed by adeno-
sine kinase (2.7.1.20, AK) which converts
adenosine to adenosine 5'-monophosphate
(AMP). Lund, Cornell and Krebs (1975)
showed that addition of adenosine (0.5
mM) to suspensions of rat hepatocytes
increased the intracellular concentration
ofadenine nucleotides up to 3-fold, indicat-
ing that AK was capable of incorporating
considerable amounts of adenosine into
the adenine nucleotide pool of rat liver
cells during a 60 min incubation; neverthe-
less, under these conditions 80% of the
added adenosine was deaminated by ADA.
Chan et al. (1973) showed that a mutant
fibroblast line, which lacked AK, excreted
inosine and hypoxanthine into the tissue-
culture medium, and they suggested that
AK, by opposing ADA, prevented the
capacity of the other enzymes of the
"adenosine cycle" from being exceeded.
These observations suggested that it
would be ofvalue to examine the activities
ofthe opposing enzymes, ADA and AK, in
a spectrum of hepatomas of different
growth rates, and in regenerating and
foetal liver, and to attempt to relate the
activity of the enzymes to the degree of
adenosine toxicity, and the extent to
which adenine nucleotide pools were
altered in presence ofadenosine. This paper
presents data from these and other
systems, and kinetic studies with partially
purified enzymes, which attempt to clarify
the role of these opposing enzymes in
adenosine metabolism, and their relation
to cell proliferation.
MATERIALS AND METHODS
Nucleosides and nucleotides, phosphoenol-
pyruvate and pyruvate kinase were obtained
from Sigma Chemical Company, St. Louis,
Missouri. [G-3H] Adenosine (5000 mCi/mmol)
was purchased from the Radiochemical
Centre, Amersham, and DE81 ion-exchange
filter discs from Whatman, Inc., Clifton, New
,Jersey. Dipyridamole, also known as 2,6-bis-
(diethanolamino)-4,8-dipiperidino-pyrimido-
(5,4-d) pyrimidine was a product of Ciba-
Geigy Corporation, Summit, New Jersey.
Other reagents w%vere from local suppliers,
analytical grades being used where available.
Animals and tumours.-Hepatomas and
kidney tumours were maintained as bilateral
s.c. transplants. Male ACI/N rats were used
for Hepatomas 3924A and 3683, and male
Buffalo ratsforallothertumours. Thetumours
were harvested at a volume of 5-20 ml. For
regenerating liver experiments, ACI/N rats
were used, and partial hepatectomy and sham
operations were performed by the standard
method (Higgins and Anderson, 1931). For
experiments with foetal and neonatal rats,
and for tissue distribution studies, Wistar
rats were used.
Tissue extraction.-Rats were stunned, de-
capitated and bled, tissues were excised, finely
minced with scissors, and suspended in 0-25 M
aqueous sucrose solution buffered to pH 7-2
with 0-02 M Tris HC1. Ten per cent (w/v)
homogenates were prepared by homogenizing
tissues for 30 sec at 600 rev/min in a Thomas
tissue grinder fitted with a motor-driven
teflon pestle. Homogenates were centrifuged
for 1 h at 105,000 g, and the supernatant
fraction (cytosol) was used for enzyme assays.
The extracts were kept at 0-40C during and
after preparation.
Adenosine deaminase assay.-The assay
method was based on that of Kalekar (1947).
The sample euvette contained 2-35 ml of
0415 M potassium-phosphate buffer, pH 7 2,
and 0u05 ml ofenzyme preparation. Reference
cuvettes contained 2-45 ml of the buffer and
0 05 ml of enzyme. After equilibration to
37°C, reaction was started by addition to the
sample cuvette of041 ml of2-5 mm adenosine
solution. The reaction was followed at 265 nm
in a Cary model 118 CX double-beam spectro-
photometer, fitted with an automatic multiple
sample programmer and cuvette positioner.
Under these conditions reaction rates were
linear for at least 5 min, and proportionate to
amount of enzyme up to at least 6 x the
usual amount. The molar optical-density
change at 265 nm for the ADA reaction was
redetermined for the present study, at
physiological conditions of pH and ionic
strength, and found to be 8-5 x 103/cm. ADA
rates measured in this way were about 72% of
Vmax, for both liver and hepatoma enzymes.
Higher rates could be obtained by using
increased adenosine concentrations, but this
resulted in greater interference from stray
light, with consequent increase in optical
noise and poorer reproducibility. Thus, ADA
activity was determined as described above,
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and Vmax values were calculated by multiply-
ing measured rates by 1.4.
Adenosine kinase assay.-This was adapted
from the method of DeJong and Kalkman
(1973). The reaction mixture contained Tris-
HC1 buffer (7.5 ,umol) dithioerythritol (0.03
/mol), KC1 (0415 ,mol), MgC12 (0.075 ~umol),
ATP (0.15 tmol), phosphoenolpyruvate (0-15
~tmol), 3H-labelled adenosine (0-015 tmol;
0-25 ,tCi), pyruvate kinase (0.75 iu) and
enzyme preparation (usually 10 1l of a 5-fold
dilution of 105,000 g supernatant fraction of
10% homogenate) in a final reaction volume
of 0.15 ml. The various components were
added to microfuge tubes, mixed by a 10 sec
centrifugation and then incubated at 37°C
for 10 min. Reaction blanks used boiled
enzyme. Reaction was stopped by boiling for
3 min, and precipitated protein was sedi-
mented by a 30 sec spin in the microfuge. Ali-
quots ofthe supernatant fraction (25 ~1) were
applied to 2-5 cm-diameter discs of anion-
exchange paper (Whatman, DE81). Unreacted
adenosine was removed by 3 successive 5 min
washes in 150 ml of aqueous ammonium
formate (1 mM) followed by 5 min washes in
distilled water and absolute ethanol. The
washed discs were then combusted in a
Packard Model 306 sample oxidizer; combus-
tion products were absorbed in Monophase 40
scintillation fluid (Packard) and measured by
scintillation counting. Under these conditions,
reaction rate was proportional to time up to
4 min, and to enzyme amount up to 25 jul1 of
2% homogenate.
Cell culture.-Hepatoma cultures were
maintained in McCoy's medium 5A, supple-
mented with penicillin (100 u/ml) and strepto-
mycin (100/ug/ml), and 10% horse serum
(which, unlike foetal calf serum, contains no
ADA). The origins, properties, and mainte-
nance of the Morris Hepatoma Culture Lines
3924A, 8999R and 8999S are described by
Jackson, Williams and Weber (1976) and
Jackson and Weber (1976). Novikoff cells
were the subline NISI-67 (Plagemann and
Swim, 1966). Hepatoma 7795 was used as the
subline MHlCl (Richardson, Tashjian and
Levine, 1969). Under these conditions mean
log-phase doubling times were: Novikoff,
12h; 3924A, 16h; 8999R, 31 h; 8999S,
63 h; 7795, 95 h.
Hepatocyte preparation.-This was by the
method of Berry and Friend (1969), modified
as described by Harris (1975).
Assays of ATP, ADP and AMP.-These
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were measured chromatographically on a
10 x 0-6 cm column of Aminex A-27 anion
exchange resin (Bio-Rad Laboratories, Rich-
mond, California) eluted with alkaline citrate
buffer gradients, as described by Khym
(1975).
Protein assay.-Protein was determined by
the method of Lowry et al. (1951), using
bovine plasma albumin as standard.
RESULTS
Kinetic properties of liver and hepatoma
enzymes
For kinetic studies, ADA and AK were
partially purified from rat liver and from
rapidly growing Hepatoma 3924A as
described by Streeter et al. (1974). The
105,000 g supernatant fractions from 30 g
oftissue were treatedwith solid ammonium
sulphate, and the protein precipitating
between 55% and 90% saturation was re-
dissolved in 3.5 ml of a buffer consisting of
10 mM Tris HC1 (pH 7.5), 10 mM MgC12,
1 mM dithiothreitol and 0.075 M KC1 (Buf-
fer A) and applied to a column of Sepha-
dex G-100 (2 cm2 x 90 cm) eluted with the
same buffer. Peaks of AK and ADA over-
lapped. The active fractions were pooled
and applied to a 7 cm2 x 20 cm column of
DEAE-cellulose (Whatman DE52). This
column was eluted with a linear gradient
for which the starting buffer was Buffer A
without KC1, and the high-ionic-strength
eluent was the same buffer containing
0.3 M KC1. As described by Streeter et al.
(1974), AK and ADA were completely
separated by this column. The ADA, about
45-fold purified relative to the 105,000 g
supernatant fraction, was used for kinetic
studies without further purification. The
AK was concentrated by precipitating
with ammonium sulphate, re-dissolved,
and further purified on a column (4 cm2 x
60 cm) of Sephadex G-75 eluted with
Buffer A. The resulting AK preparation,
about 50-fold purified relative to the
105,000 g supernatant fraction, was used
for kinetic studies.
Michaelis constants for adenosine of the
ADA preparations was measured by
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assaying the enzyme in triplicate at a
range of adenosine concentrations (5, 10,
20, 35, 50, 75, 100, 150 and 250 jumol/l).
Saturation curves were roughly hyperbolic,
with no indication of high substrate
inhibition. The Michaelis constants, as cal-
culated by the method ofWilkinson (1961)
were 37±4 ,molar (liver ADA) and 45±7
ptmolar (Hepatoma 3924A enzyme). Both
liver and hepatoma ADA were subject to
product inhibition by inosine; results for
the rat liver enzyme are shown in double
reciprocalforminFig. 1. The inhibitionwas
competitive with adenosine, and Ki,siope,
as calculated by the computer programme
"COMP" (Cleland, 1963) was 280 jum; the
corresponding value for the hepatoma
3924A enzyme was 345 MM.
AK activity was compared at a range of
adenosine concentrations (0-25, 0 5, 1P0,
1P5, 2-0, 5 0, 10'0 and 25 0 FLM). No excess-
substrate inhibition was seen at the higher
adenosine concentrations. Michaelis con-
stants of AK for adenosine, as calculated
by the method of Wilkinson (1961), were
1-3 ,uM (liver) and 1P5 ,uM (Hepatoma
3924A). In view of the observation of
Murray (1968) that free ATP, rather than
Mg-ATP, was the best phosphate donor
for AK, ATP saturation curves were
studied at a constant Mg2+ concentration
of 0 5 mm which was found to be the
0 10 20 30 40 50 60
L/(AdenosineI mM 1
FIo. 1. Inihibition of adlenosine (leaminase
(ADA) fiom rat liver by inosine. A 45-fold
purifie(d enzyme preparation was used, an(I
assays were (lone as (lescribell in the text.
Open circles, control; closed circles, inosilne
at 38 jc/l; Openi s(Ilares, inosinie at 72 pMr.
0 1 2 3 4 5 6 7 8 9 0.2 0.4 0.6 0. 1.0
ATP (iiiNI) -, ATP
FIG. 2. Effect of ATP concentration on the
velocity of the AK reaction. A 50-fold
purifie(1 rat liver enzyme preparation was
used, and standardl assay con(litions, except
that phosphoenolpyruvate and pyruvate
kinase were omittedl from the reaction
mixture. A: Saturation curve. B: The same
dlata, at ATP concentrations of 2 M ancl
above, (lisplaye(d as a Hill plot, where a--
mea.sured velocity divi(led by Vinlax.
optimal level in the present study when
measured at an ATP concentration of
1 mm. The ATP saturation curve for the
liver enzyme is shown in Fig. 2(a). The
apparent Km value, calculated from the
rates obtained at ATP concentrations of
1 mm or less, was 230 MM. At ATP con-
centrations of 2 mM and above, as shown
in Fig. 2(a), strong product inhibition was
caused by ATP. Fig. 2(b) is a Hill plot of
the same data, for ATP concentrations of
2 mm and above. The slope of this plot is
2-0. Since AK is not believed to be a
multiple subunit enzyme, a possible expla-
nation of the high value of the Hill co-
efficient for excess ATP inhibition is that
ATP binds to both the AMP and ADP
product sites. When the experiment was
repeated with Mg-ATP instead of free
ATP, very similar results were obtained,
with 5000 inhibition reached at an Mg-
ATP concentration of 3.4 mM. The AK
from Hepatoma 3924A was also susceptible
to excess-substrate inhibition by ATP. A
concentration of 3.5 mml (free ATP) gave
5000 inhibition, relative to the rate ob-
tained at 1 mm, which was the optimal
ATP concentration for the tumour enzyme,
as it was in normal liver AK. ADP and
AMP were effective inhibitors of rat liver
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TABLE I.
Adenosine
tides*
Nucleotidle
A.DP
AM\IP
GDP
GTP
UTP
UD)P
UJIP
CDP
-Inhibition of Rat Liver
Kinase (AK) by Ribonucleo-
Concn.
(mm)
0-13
() * 33
1 00
0 -13
0 33
1*00
0 33
1 0()
2 00
2 00
0 :33
100
0 33
1*00
2 00
0 33
AK activity
(0/ of uninhibite(d
control)
65
45
4
83
63
47
86
65
70
95
97
96
102
93
85
103
pyridamole (0.8 mM) was added to inhibit
ADA, since in some tissues the ADA
activity greatly exceeded that ofAK. Pre-
liminary experiments with the liver en-
zymes showed that this concentration of
dipyridamole inhibited ADA by 970 and
AK by 13%. The highest specific activity
of AK was found in liver. Many tissues,
however, have higher ADA activity than
liver, and the highest activities were
present in intestinal mucosa and thymus.
Table II also shows the ratio of maximal
activities for the 2 enzymes. Only in liver
and erythrocytes was AK activity higher
than ADA. The 2 activities were equal in
brain, and in all the other tissues examined
ADA activity washigher thanAK activity.
* A 50-fold purified prepaiation of enzyme was
use(d foi these experiments; activity was measure(d
by the standard assay, as described in "'Materials an(l
AMethods".
AK; lesser degrees of inhibition were
caused by other ribonucleotides (Table I).
Organ and tissue distribution of ADA and
AK
The activities of the two enzymes were
measured in a series of organs and tissues
of adult Wistar rats. Results are summar-
ized in Table II. In the AK assays, di-
Activities of ADA and AK in tumours
Specific activities of the 2 enzymes, as
measured by the standard assays, for 12
transplantable rat hepatomas, are sum-
marized in Fig. 3. In these studies, the
mean ADA specific activity in cytosol
preparations from 18 control rats was
1760+70 (s.e. mean) nmol/h/mg cytosol
protein. Specific activity of ADA in
cytosol preparations from the hepatomas
is shown as a percentage of the control
liver value. In the hepatomas of slow or
medium growth rate, with intervals be-
TABLE II. Adenosine Deaminase (ADA) and AK Activities in Rat Tissues*
Organi or tissuIe
Liver
Kicdney cortex
Heart
Testis
Spleen
Lung
Epi(lidlymal fat pad
Brain (ceiebra)
Skeletal muscle
(gastrocnemius)
Small intestine (mtucosa)
Thymus
Bone mairrow (femoral)
Erythrocytes
Peripheral leucocytes
Bloo(d plasma
Cytosol protein
(mg/g wet wvt)
9:3+3
74± 4
58X4
47 9
71 - 6
79 ± 5
18- 3
32±2
55±-4
58+6
5:3±2
84-1- l0
360- 32
90±6
6:3±3
* Measurled as dlescribe(I in the 'Methods section; iD the AK assay, 0 -8 mAi (lipyri(lamole was present, to
iinhibit ADA. Activities expresse(l as nmol/h/mg protein (in parentheses, as 0° of the liver activities). Protein
was measured by the metho(l of LowriY et al. (1951), except for erythrocyte haemolysates, where the biulet
inetho(d wNas usedl (Gornall et ail., 1949). Figures are mean value(; for quadlruplicate samples.
ADA
1,510 (100)
6,410 (424)
'3,870 (256)
3,880 (257)
13,900 (923)
10,900 (719)
2,270 (150)
713 (47)
1,130 (7.5)
41,900 (2,780)
47,700 (3,160)
1,800 (119)
36 (2 4)
627 (42)
21 (1 4)
AK
4,270 (100)
1,520 (36)
1,280 (30)
1,160 (27)
1,010 (24)
987 (23)
733 (17)
713 (17)
687 (16)
610 (14)
419 (10)
207 (4 8)
144 (3.3)
60 (1-4)
0
ADA/AK
0 35
4-2
11 0
3 -3
13-8
11*0
3-1
1.0
1 7
68-7
113 -9
8 7
0-25
10-4
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450
400
350
300
n 250
200
150
100
50
<: 0
100
c 80
60
40
20
D 100
° 50
0
Norilal Slow Medium ,, _Rapid
CLiver 0.
,, ive Hepatomas in order of increasing growth rate
Fi'e. "I. Activities of ADA and AK in
cytosol preparations from rat hepatomas.
The activities are expressed as of levels
in control rat livers. The absolute activities
of the 2 enzymes in the control livers aie
given in the text. Also shown is the ratio of
Xrnax of the 2 enzymes, and the cytosol
proteiin content ofthehepatomas,expressed
as a 0 of the mean control liver value
(91 mg/g wet wvt).
tween successive transplants ranging from
12 to 5 months, ADA activity was in the
normal range (80% to 130% of liver
activity). However, in 5 hepatoma lines
of rapid growth rate (interval between
transplants of 1 month or less) ADA
activity was significantly increased, at
least doubled in every case, and reaching
4*2-fold in the most rapidly growing liver
tumour.
The mean±s.e. mean for AK activity
in normal liver from 19 control rats was
38404 160 nmol/h/mg cytosol protein.
Fig. 3 shows hepatoma activity as per-
centages of the control liver value. The
AK activity was decreased in all the
tumours; this decrease was statistically
significant (P<0*05 in Student's t test) in
every case except Hepatoma 20. In the
slow and medium growth-rate hepatomas
specific activity was 64-85% ofthe control
liver value, but in tumours ofrapid growth
rate the AK activity was further decreased
(3700 of control, or less) falling to 6% of
control in the most rapidly growing
hepatoma. Thus the AK activity in
hepatomas showed a negative correlation
with growth rate. Kendall's rank-correla-
tion coefficient for AK activity and growth
rate was 0-697, statistically a highly
significant correlation (P<0 O1). Fig. 3
also presents the ratio of maximal activi-
ties of ADA/AK in the hepatomas. In the
various normal liver samples examined,
this ratio was in the range 0-35-0 46. The
ratio was slightly higher in the slow and
medium growth-rate neoplasms (0.47-
0.76) and considerably increased in the
hepatomas of rapid growth rate. In the
fastest-growing hepatoma this ratio
reached 32 1, a higher value than in any
of the normal tissues examined, except
intestinal epithelium and thymus.
Activities of the two enzymes were also
measured in two transplantable kidney
tumours. In 8 samples of normal adult
rat renal cortex, specific activity of ADA
was 6a15 ,tmol/h/mg protein (soluble pro-
tein 76 mg/g wet wt). In kidney tumour
MK1, specific activity of ADA was 23%
of that in the kidney control; in kidney
tumour MK3, ADA specific activity was
22°, of control (protein contents were:
MK1, 78mg/g;MK3, 72 mg/g). Thetumour
ADA activities given are means ofquadru-
plicate samples, with scatter between
replicates not greater than ± 120%. Speci-
fic activity ofAK in normal kidney cortex
was 1 54,mol/h/mg protein (mean for 8
samples). Activity in kidney tumour MKI
was 80% ofthe normal kidney control, and
ADA in kidney tumour MK3 was 5300
of control (means of quadruplicate
samples). Ratios ofADA/AK in this study
were thus: control renal cortex, 4'0;
kidney tumour MK], 1-1 5; kidney tumour
MK3, 1*66.
ADA and AK in regenerating liver
Fig. 4 shows activity ofADA and AK at
a number of intervals after partial hepa-
tectomy or sham laparotomy. The opera-
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Fic(.. 4. Activities of ADA an(l AK in rat,
liver after partial hepatectomy. All points
are mean valuies for groups of5 or 6animals.
Vertical bars indicate s.e. mean. Experi-
mental dletails are given in the text.
Symbols: 0, AK in sham-operated rat
liver; n, AK in regenerating rat liver; 0,
ADA in sham-operated( rat liver; *, ADA
in regenerating rat liver.
tions were timed such that all animals were
killed at 10.00 a.m. Cytosol fractions were
prepared and ADA and AK activities
measured by the standard assays. At the 6
intervals examined between 12 and 96 h
after operation, the activity of ADA
showed no significant change. In contrast,
the AK activity of regenerating liver was
already significantly decreased, relative to
sham-operated controls, by 12 h after the
operations. At 24 h the AK activity in the
regenerating livers was about 60% of the
sham-operated control value; it remained
at this level at 48 h. By 72 h after opera-
tion the AK activity in the regenerating
liver samples had increased to near the
normal range. This decrease in AK activity
in the regenerating liver samples, in the
presence of unaltered ADA activity,
resulted in a ratio of ADA/AK of 0 70 in
the 24 h regenerating liver, compared to a
ratio of 0 41 in unoperated control samples
of ACI/N rat liver.
ADA and AK in differentiating liver and
kidney
Activities of the 2 enzymes in differ-
entiating liver samples, ranging from
17-day foetal rats to mature 60-day-old
rats are shown in Table IIJ. Specific
activity of ADA in the liver of foetal and
neonatal rats was significantly higher than
in adult rat liver, gradually declining with
increasing age. Specific activity of AK in
the liver of 17-day embryos was signifi-
cantly lower than the adult level. flow-
ever, it reached the adult value by the 20th
day of gestation, and thereafter remained
in the adult range until maturity. Because
the cells of foetal or neonatal liver are
much smaller than mature hepatocytes
(Table III) the number of cells/g of liver
is much higher in the immature animals.
Thus, if activity of ADA and AK were
expressed per cell (Table III), both
enzymes, on this basis, had lower activity
in the foetal or neonatal liver than in
adult liver. It was interesting to compare
the ratio ADA/AK at the various stages of
development, since this ratio is independ-
ent ofthe units ofthe individual activities;
the ADA/AK ratio in the 17-day foetal
liver was 1*5 (3 7x the adult liver ratio),
declining with increasing age, and
approaching the adult value by 31 days
after birth.
Table III also shows ADA and AK
activities in neonatal kidney. Specific
activity of ADA was higher, and that of
AK lower, in neonatal kidney than in
adults. Activities of both enzymes were
lower in the neonatal kidney, on a per-
cell basis, than in adult kidney cortex. As
with the liver, the ratio of ADA/AK was
higher in neonatal kidney than in the
mature organ.
Growth inhibition of cultured hepatokna
cells by adenosine
Fig. 5 summarizes the growth-inihibitory
effect of adenosine against 5 rat hepatoma
lines in culture. It was shown by Ishii and
Green (1973) that the growth-inhibitory
effect of adenosine is cell-density depend-
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Fie(-t. 5. Effect of adlenosine on growth of
established hepatoma lines in culture.
Ctultures were initiate(l at 2 x 105 cells in
10 ml medium in 25 cm2 flasks. Adenosine
was ad(led to the indicated concentration,
andl further equal additions of adenosine
were made after 24 and 48 h. Cultures were
countedl after 72 h, andl iesults were ex-
pressedl as increase in cell count relative to
the increase in cell count of control
cultures.
ent, so all cultures were initiated at the
same density (20,000/ml). Preliminary
studies showed that more than 9000 of
adenosine was removed from the medium
of these cultures after 24 h, so successive
additions of adenosine were made at the
time of initiation and after 24 and 48 h.
This removal ofadenosine was presumably
caused by the intracellular ADA, since
the horse serum used to supplement the
culture medium contained no ADA. Cul-
tures were counted after 72 li, and the cell
counts, as percentages of control values
(no adenosine) are plotted in log-log form
in Fig. 5 as a function of adenosine con-
centration. The sensitivity of the cells to
adenosine toxicity showed a negative
correlation with growth rate (correlation
coefficient -0.83). Table IV shows the
5000 growth-inhibitory concentrations
(ID50) for adenosine, as measured in 72 h
experiments with the 5 hepatoma lines
in culture. Specific activities of ADA and
AK in the 5 lines are also tabu'lated (with
the enzyme activities of isolated normal
liver cells for comparison). In these experi-
ments, cells were sedimented at 1100 g for
7 min, suspended in Tris-HCl buffer,
pH 7f2, 0 05 M, and then successively
frozen in liquid N2 and thawed in a 37°C
water bath, 4 times, to lyse the cells.
Lysates were centrifuged at 105,000 g for
60 min, and activities measured by the
standard assays in the supernatant frac-
tion. ADAandAKactivitiesinthe cultured
hepatoma cells were in general similar to
the levels in the solid tumours. All cell
lines showed lower AK activity than
normal liver; the decreases were small in
the slow-growing lines 7795 and 8999S,
and more marked in the faster-growing
tumours. ADA activity was higher in all
the hepatoma lines than in normal liver.
Its activity was 133% of liver activity in
the slowest-growing line, 7795, and 2-3.5-
fold the liver value in the other hepatoma
lines. The ratio ADA/AK had a highly
significant correlation with growth rate
(r 0.979) and with the adenosine ID50
value (r 0.921). It thus appears that, for
growth in the presence of extraneous
adenosine, the increased ability of hepa-
tomas to deaminate adenosine and de-
creased capacity to phosphorylate adeno-
sine confers a selective advantage.
Incorporation of adenosine into ribo-
nucleotide pools
Lund et al. (1975) showed that incuba-
tion of isolated rat hepatocytes with ade-
nosine produced large increases in cellu-
lar ATP, and smaller increases in ADP and
AMP. We designed similar experiments
using Hepatoma 8999R and Novikoff cell
lines, to determine the extent to which
this response to adenosine is modified by
the changes in activity of the competing
enzymes ADA and AK, as observed in
hepatomas. Isolated normal hepatocytes
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TABLE IV.-ADA and AK Activities (as ,rnol/h/mg protein) in Cultured
Hepatoma Cellst
Cell
type
Liver
7795
8999S
8999R
3924A
Novikoff
Doubling
time (h)
V5
63
31
16
12
ID50
for
adenosine
(mM)
0 04
0 04
0 -06
0-21
1-4
ADA
1-50 (100)t
1-99 (133)
3-97 (265)
3 -14 (209)
4-30 (287)
5-31 (354)
AK
3-56 (100)
3-08 (87)
3-21 (90)
1-64 (46)
0-92 (26)
0-65 (18)
* Normal liver cells do not divide in culture under these conditions.
t Activities are means of duplicate assays on triplicate cultures.
t As % of normal liver value.
and cultured 8999R and Novikoff hepa-
toma cells were incubated in McCoy's
Medium 5A (,3 x 107 cells/5ml) supple-
mented with 10% horse serum, and con-
taining various concentrations of 3H-
labelled adenosine (40 mCi/mmol). After
60 min at 37°C, cells were extracted with
4.5% perchloric acid, and extracts were
neutralized with 4 N KOH, and analysed
for ATP, ADP and AMP by the chromato-
graphicmethodofKhym (1975). Theradio-
activity in each of these peaks was meas-
ured by scintillation counting. Loss of
adenosine from the incubation medium
was measured optically, as described by
Moellering and Bergmeyer (1974). Data
are shown in Table V. Results withhepato-
cytes at the highest adenosine concentra-
tion studied (300 ,M) were similar to the
results obtained by Lund et al. (1975) with
500 ,uM adenosine: total adenine nucleo-
tides increased by more than 100%, most
of the increase being ATP. Twenty per
centoftheadenosineutilizedwasrecovered
as adenine nucleotides, the remainder
presumably being deaminated. At the
lower adenosine concentrations studied
(10 and 30 uM) more than half the adeno-
sine was recovered in adenine nucleotides.
In cells of Hepatoma 8999R, 60 min incu-
bation with 300 /M adenosine gave a 40%
increase in adenine nucleotides. At this
adenosine level, 90% was deaminated, and
the proportion of adenosine deaminated
at the lower concentrations studied was
higher than in liver. In Novikoff cells the
effect ofextracellular adenosine on adenine
nucleotide levels was even smaller, and
most of the adenosine was deaminated at
all 3 concentrations studied. Although it is
possible that some of the radioactive
adenine nucleotides were formed by the
TABLE V.-Effects of Extracellular Adenosine on Liver and Hepatoma Cells
Cell
type
Liver
8999R
Novikoff
Adenosine
conc. (,uM)
0
10
30
300
0
10
30
300
0
10
30
300
Adenine nucleotide contents (,umo]/109 cells)*
, 5~~~~~~~~~~~ ATP
9 6
9 3
11*0
21 4
5.9
6 0
6 4
8 8
5 0
5*1
5 4
6 6
ADP
2 9
3 2
3 0
4.5
1-8
1.9
2 0
2 1
1.5
1 7
1 7
1 6
AMP
12
1.0
1 2
1 7
0 8
0 9
0 9
0 9
0 6
0 8
0 7
0 7
* Means of analyses of duplicate cultures. Incubation time was 60 min.
t In pareoitheses, as % of the control value (without adenosine).
Total
13 7 (100)t
13 5 (99)
15 2 (111)
27 6 (201)
8 5 (100)
8-8 (104)
9.3 (109)
11-8 (139)
7-1 (100)
7-6 (107)
7-8 (110)
8-9 (125)
ADA/AK
0 42
0-65
1-24
1-92
4-65
8-12
adenosine
deaminated
26
44
80
55
75
90
77
87
93
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route adenosine -*inosine->hypoxanthine
-IMP--*adenylosuccinate--AMP, the rate-
limiting enzyme ofthat sequence (adenylo-
succinate synthetase) is less active than
AK, by a factor of between 7 and 100 in
the various cell types (Jackson, Morris
and Weber, 1977) and the proportion of
adenosine label recovered in adenine
nucleotides showed a good correlation
with the ADA/AK ratio in the 3 cell
types.
D)1SCUSSION
The examiniation of kinetic properties
of ADA and AK suggests that the meta-
bolic fate of adenosine is controlled by at
least 3 factors. The first is the ratio of
activities of these 2 competing enzymes.
The elucidation of the behaviour of the
activities of these enzymes in normal and
neoplastic tissues was the primary aim of
the present study, and the conclusions will
be discussed in detail below. The second
controlling factor is the ratio of Km values
for the 2 enzymes. The very low Km for
adenosine ofAK (1.3 Mm), compared to the
higher value of ADA (37 yuM), ensures that
adenosine is conserved at low concentra-
tions. Data in Table V show that the pro-
portion of adenosine deaminated increased
with concentration. This arrangement
may enable the cell to recycle small
amounts of adenosine resulting from
cellular AMP phosphatase activity, whilst
protecting it from the toxic effects of high
extracellular adenosine production. The
third factor that controls adenosine utiliza-
tion is the feedback inhibition of AK by
AMP, ADP and ATP. Data shown in
Table I and Fig. 2 indicate that these
effects are appreciable at physiological
nucleotide levels, though these inhibitions
do not provide a completely effective
homoeostatic mechanism, since incubation
of cells with high concentrations of
adenosine led to an elevated cellular ade-
nine-nucleotide content. The product in-
hibition of ADA by inosine was feeble,
and may be considered as of no physio-
logical importance.
The results ofthe ADA tissue and organ
distribution study (Table 11) closely
resembled earlier surveys of this enzyme
in rat tissues (Clarke et al., 1952; Purzy-
cka, 1962; Brady and O'Donovan, 1965).
The novel aspect of the present distribu-
tion study was the simultaneous determi-
nation ofADA and AK, which made possi-
ble accurate information concerning the
ratio of these competing enzymes. Note-
worthv observations were: both ADA ac-
tivity and the ADA/AK ratio were highest
in thymus, and next highest in intestinal
epithelium. AK activity was highest in
liver, and next highest in renal cortex. In
brain the ADA/AK ratio was about unity;
this ratio was < 1 in erythrocytes and liver,
and >1 in all other tissues. The ADA/AK
ratio was lowest in erythrocytes; this
would presumably result in a proportion-
ately high incorporation of adenosine into
adenine nucleotides, consistent with this
route being an important source of ery-
throcyte ATP, as proposed by Lerner and
Lowy (1974). The ADA activity and ADA/
AK ratio were considerably higher in
cardiac muscle than in skeletal muscle,
which was ofinterest in view ofthe cardio-
toxicity of adenosine.
In general, ADA activity and the ADA/
AK ratio were high in organs of cell pro-
liferation (e.g. thymus, intestinal epithe-
lium). In the hepatoma series, a clear
pattern was evident. AK activity was
lower than the normal liver value in all 12
hepatomas. In the tumours of slow or
intermediate growth rate, with intervals
between successive transplant generations
of 5 months or more, the AK activity was
in the range of 64-85% of the liver value.
In 5 rapidly growing hepatomas (trans-
plant intervals I month or less) there were
more marked decreases in the AK activity.
These rapidly growing tumours were the
only ones to show significant changes in
ADA activity, relative to normal liver (at
least doubled). Thus it is clear that the
consequence of these enzyme activity
changes in hepatomas would be that
proportionately more adenosine would be
deaminated, and less phosphorylated,
than in normal liver, with the most
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markedl effects observed in hepatomas of
rapid growth rate. This prediction from
the enzvme levels is supported by the data
of Table V, in which adenosine phos-
phorylation and deamination were meas-
ured in suspensions of isolated normal
hepatocytes and cultured hepatoma cells.
TI'he increased deamination and decreased
phosphorylation of adenosine appear to
confer increased resistance to adenosine
toxicity upon the cells. The data of Table
IVz show that Novikoff rat hepatoma cells,
with an ADA/AK ratio 12 x that of
Hepatoma 7795, are 35 x as resistant to the
growth-inhibitory effect of adenosine.
The changes in activity ofADA and AK
cannot be regarded as stringently linked
with the neoplastic transformation. Ac-
tivityofADA showedno significant change
in the slow-growing hepatomas (Fig. 3)
and low values in peripheral leucocytes
from chronic lymphocytic leukaemia
(Scholar and Calabresi, 1973; Meier, Cole-
man and Hutton, 1976). However, the
marked increases of ADA activity in
rapidly growing hepatomas (Fig. 3) anid
in acute leukaemia cells (Smyth and
Harrap, 1975; Meier et al., 1976) suggest
that this enzyme may correlate with the
process of malignant progression. A lack
of correlation of ADA activity with cell
proliferation per se seems to be indicated
by the unchanged values in regenerating
liver and neonatal liver. On the other
hand, AK, which exhibited a negative
correlation with growth rate in the hepa-
tomas, also showed a marked and statisti-
cally significant decrease in regenerating
liver, and was low in foetal and neonatal
liver. The decrease in AK activity is thus
found in both malignant and nonmalig-
nant states of cell proliferation, though it
was most marked in the rapidly-growing
hepatomas. The changeswhichweobserved
in ADA and AK activities appear to be
quantitative; no differences in kinetic or
chromatographic properties were seen
when the two enzymes were partially
purified from rat liver and Hepatoma
3924A. The question whether multiple
forms of these enzymes occur in rat liver
and hepatomas will fortm the basis of
future studies.
The reciprocal behaviour of the oppos-
ing enzymes ADA and AK, most markedly
expressed in the rapidly growing neo-
plasms, is in line with previous observa-
tions on the behaviour of antagonistic
enzymes in carbohydrate, purine and
pyrimidine metabolism (Weber, 1977).
The changes reported above in activity of
the competing enzymes ADA and AK
should confer a selective advantage upon
hepatoma cells in the presence of extra-
cellular adenosine. That ADA activity
influences adenosine toxicity was demon-
strated by Harrap and Paine (1977), who
showed that coformycin, a potent and
specificinhibitor ofADA, greatly increased
the sensitivity of lymphoblasts to adeno-
sine. In solid tumours, which often contain
areas of necrotic tissue, the adenosine
concentration might be appreciable, and
the protection from adenosine toxicity
afforded by increased deamination and
reduced phosphorylation could have a
marked effect on tumour survival. To
establish the magnitude of adenosine
toxicity in vivo, direct measurement of
tissue adenosine levels will be necessary.
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